ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …

Abstract Introduction TETRAXIM™(Sanofi), a combined diphtheria, tetanus, acellular
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …

This randomized trial enrolled 442 infants in the Republic of Korea to assess the
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …

Abstract Introduction PENTAXIM™(Sanofi), DTaP-IPV//Hib, a pentavalent combination
vaccine for protection against diphtheria, tetanus, pertussis, poliomyelitis, and invasive …

Purpose To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-
acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV, Infanrix™ IPV …

Key point Considering that vaccination with the sIPV and DTaP overlap at the ages of 3 and
4 months in China, to reduce the burden of treatment on parents and increase vaccination …

abstract The introduction of combination vaccines plays a significant role in increasing
vaccine acceptance and widening vaccine coverage. Primary vaccination against …

Abstract In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined
diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV) …

Background: Combined vaccines are urgently needed to ensure compliance with the
increasing number of recommended vaccines for children. We evaluated the safety and …

Objective To evaluate the effectiveness and safety of DTaP-IPV/Hib combined vaccine in
comparison with commercially available DTaP (diphtheria, tetanus and pertussis) …